Market Overview

Morgan Stanley Sees High Quality Growth Story For Monsanto

Share:
Related MON
Monsanto Won't Counter ChemChina's Bid For Syngenta, Bernstein Analyst Says
Expect More Than Standard Antitrust Scrutiny For ChemChina/Syngenta Deal
Syngenta Likely To Return 20% Within The Next 6 Months (Seeking Alpha)

In a report published Thursday, Morgan Stanley analyst Vincent Andrews reiterated an Overweight rating and $150.00 price target on Monsanto Company (NYSE: MON).

In the report, Morgan Stanley noted, “Reiterate $150 year-end PT as key tenant of $200 Bull Case is now in play: a $11B (~18% DSO) buyback should not only compound the high visibility growth from Intacta Soybeans (key Base Case driver) but it should also minimize commodity price concerns (a perennial overhang on the stock).”

Monsanto closed on Wednesday at $126.73.

Latest Ratings for MON

DateFirmActionFromTo
Jan 2016Deutsche BankMaintainsBuy
Dec 2015Atlantic EquitiesUpgradesNeutralOverweight
Oct 2015JP MorganAssumesNeutral

View More Analyst Ratings for MON
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Vincent AndrewsAnalyst Color Reiteration Analyst Ratings

 

Related Articles (MON)

View Comments and Join the Discussion!

Get Benzinga's Newsletters